{"id":"https://openalex.org/W4200316859","doi":"https://doi.org/10.1182/blood-2021-153415","title":"Identification of a Novel Proliferating Cell Fraction in Chronic Lymphocytic Leukaemia with High Expression of IgM and Chemokine Receptors","display_name":"Identification of a Novel Proliferating Cell Fraction in Chronic Lymphocytic Leukaemia with High Expression of IgM and Chemokine Receptors","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W4200316859","doi":"https://doi.org/10.1182/blood-2021-153415"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-153415","doi":"https://doi.org/10.1182/blood-2021-153415","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-153415","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Daniel Friedman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Daniel Friedman","raw_affiliation_strings":["Comprehensive Cancer Centre, King's College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Centre, King's College London, London, United Kingdom","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Antony Long","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Antony Long","raw_affiliation_strings":["King's College Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King's College Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045820092","display_name":"Piers Patten","orcid":"https://orcid.org/0000-0003-3320-3034","observed_orcids":["https://orcid.org/0000-0003-3320-3034"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Piers EM Patten","raw_affiliation_strings":["Comprehensive Cancer Centre, King's College London, London, United Kingdom","King's College Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Centre, King's College London, London, United Kingdom","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"King's College Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067700049","display_name":"Robbert Hoogeboom","orcid":"https://orcid.org/0000-0002-7256-9285","observed_orcids":["https://orcid.org/0000-0002-7256-9285"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robbert Hoogeboom","raw_affiliation_strings":["Comprehensive Cancer Centre, King's College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Centre, King's College London, London, United Kingdom","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"3711","last_page":"3711"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/cxcr4","display_name":"CXCR4","score":0.7490000128746033},{"id":"https://openalex.org/keywords/cd5","display_name":"CD5","score":0.9700000286102295},{"id":"https://openalex.org/keywords/igm","display_name":"IgM","score":0.6919999718666077},{"id":"https://openalex.org/keywords/chemokine-receptors","display_name":"chemokine receptors","score":0.8960000276565552},{"id":"https://openalex.org/keywords/ccr7","display_name":"CCR7","score":0.7310000061988831},{"id":"https://openalex.org/keywords/cxcr3","display_name":"CXCR3","score":0.8650000095367432},{"id":"https://openalex.org/keywords/cxcr5","display_name":"CXCR5","score":0.9729999899864197},{"id":"https://openalex.org/keywords/cd86","display_name":"CD86","score":0.8389999866485596},{"id":"https://openalex.org/keywords/aid","display_name":"AID","score":0.6499999761581421},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.9649999737739563},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.7680000066757202},{"id":"https://openalex.org/keywords/subclonal-heterogeneity","display_name":"subclonal heterogeneity","score":0.6899999976158142},{"id":"https://openalex.org/keywords/secondary-lymphoid-organs","display_name":"secondary lymphoid organs","score":0.609000027179718},{"id":"https://openalex.org/keywords/lymph-nodes","display_name":"lymph nodes","score":0.3709999918937683},{"id":"https://openalex.org/keywords/mitotic-cells","display_name":"mitotic cells","score":0.5220000147819519},{"id":"https://openalex.org/keywords/imaging-flow-cytometry","display_name":"imaging flow cytometry","score":0.6029999852180481}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6174303889274597},{"id":"https://openalex.org/C113067387","wikidata":"https://www.wikidata.org/wiki/Q14912836","display_name":"CD5","level":3,"score":0.5939269661903381},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5325692296028137},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5193927884101868},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.4699326455593109},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.4655023217201233},{"id":"https://openalex.org/C129470790","wikidata":"https://www.wikidata.org/wiki/Q415718","display_name":"CXCR4","level":4,"score":0.4324706196784973},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42533108592033386},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.4247293472290039},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.42366737127304077},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.41751545667648315},{"id":"https://openalex.org/C151872237","wikidata":"https://www.wikidata.org/wiki/Q1410759","display_name":"Homing (biology)","level":2,"score":0.41024187207221985},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3898981213569641},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.36956435441970825},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.33645540475845337},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.24597346782684326},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.20449000597000122},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1640394628047943},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.09715375304222107},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-153415","doi":"https://doi.org/10.1182/blood-2021-153415","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-153415","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2586334173","https://openalex.org/W4405500332","https://openalex.org/W2587768009","https://openalex.org/W2981054714","https://openalex.org/W9699790","https://openalex.org/W2555823125","https://openalex.org/W2810233281","https://openalex.org/W4387020350","https://openalex.org/W2428286253","https://openalex.org/W2552101815"],"abstract_inverted_index":{"Abstract":[0],"Chronic":[1],"lymphocytic":[2],"leukaemia":[3],"(CLL)":[4],"is":[5,324,338,480],"characterised":[6],"by":[7,46,506],"the":[8,16,41,47,105,136,159,207,228,251,256,265,284,298,331,342,377,400,411,417,428,447,470,475,499,526,543,576],"accumulation":[9],"of":[10,50,61,63,80,111,161,163,206,225,235,274,289,296,321,333,344,391,410,427,467,472,483,498,508,525,539,545,551,567],"malignant":[11],"CD5+":[12],"B":[13,31],"cells":[14,103,114,165,221,248,263,323,335,347,423,444,450,488,516,541,574],"in":[15,40,65,70,99,124,227,255,264,326,336,348,399,416,451,491,494,511,521,542,575,594],"peripheral":[17],"blood":[18],"(PB),":[19],"secondary":[20,327],"lymphoid":[21,328],"tissues":[22],"and":[23,87,120,176,192,222,238,294,307,318,364,384,394,437,557,565,585],"bone":[24],"marrow.":[25],"Currently":[26],"considered":[27],"an":[28,357],"incurable":[29],"disease,":[30],"cell":[32,73,151,178,199,229,387,457,583],"receptor":[33,84],"(BCR)":[34],"signalling":[35,52,122],"plays":[36],"a":[37,275,352,368,464,535],"key":[38,465],"role":[39],"disease":[42],"aetiology":[43],"as":[44,55,203,504],"evidenced":[45,505],"therapeutic":[48,591],"success":[49],"BCR":[51,121,568,600],"inhibitors":[53],"such":[54],"ibrutinib.":[56],"Previous":[57],"studies":[58],"using":[59,170,270,361],"incorporation":[60],"2H-labelling":[62],"DNA":[64],"vivo":[66],"demonstrated":[67],"sub-clonal":[68],"heterogeneity":[69],"PB":[71,139,164,370,378,486,544],"CLL":[72,140,168,322,346,487,546,596],"fractions":[74,129,152,187,299],"sorted":[75],"based":[76,188],"on":[77,189,376,474],"reciprocal":[78],"densities":[79,191],"chemokine":[81],"C-X-C":[82],"motif":[83],"4":[85],"(CXCR4)":[86],"CD5.":[88],"The":[89,453],"CXCR4":[90,106,237,245,266,279,401,420,441,454,476,500,527,571],"loCD5":[91,246,421,455,501],"hi":[92,247,268,281,403,422,443,456,478,502,528,573],"fraction":[93,109,200,230,254,269,282,404,458,479,538],"was":[94,201,406],"shown":[95,461],"to":[96,116,173,193,311,367,382,408,462,485,563,599],"be":[97,446,463],"enriched":[98],"recently":[100],"born":[101],"proliferating":[102,177,220,253,334,345,540],"while":[104],"hiCD5":[107,241,267,280,402,442,477,572],"lo":[108],"consists":[110],"resting,":[112],"quiescent":[113],"thought":[115],"reflect":[117],"their":[118],"migratory":[119],"histories":[123],"tissue.":[125],"Whilst":[126],"these":[127],"proliferating/resting":[128],"have":[130,156,533],"since":[131],"been":[132,143,460],"more":[133],"closely":[134,579],"examined,":[135],"remaining":[137],"bulk":[138,429],"population":[141,415],"has":[142,459],"left":[144],"relatively":[145],"unexplored":[146],"leaving":[147],"other":[148],"therapeutically":[149],"relevant":[150],"undetected.":[153],"Here,":[154],"we":[155,215,259,350,532],"comprehensively":[157],"analysed":[158,351],"phenotype":[160,332,343],"subpopulations":[162],"from":[166,356],"11":[167],"patients":[169,547,597],"flow":[171,272,362],"cytometry":[172,273,363],"identify":[174],"activated":[175,306,582],"fractions.":[179,388],"CD19":[180,210,412],"+CD5":[181,211,413],"+cells":[182],"were":[183,380,397,523],"divided":[184],"into":[185],"9":[186],"CXCR4/CD5":[190],"permit":[194],"comparisons":[195],"between":[196],"fractions,":[197],"each":[198],"defined":[202],"containing":[204],"1-2%":[205],"total":[208],"clonal":[209],"+":[212,414],"population.":[213],"Surprisingly,":[214],"detected":[216],"enrichment":[217],"for":[218,309,315,425,489,560,590],"Ki67+":[219],"high":[223,549],"expression":[224,233,287,550],"AID":[226],"with":[231,548],"highest":[232,285,325,398],"levels":[234,288,390],"both":[236,392,561],"CD5":[239],"(CXCR4":[240],"hi),":[242],"demonstrating":[243],"that":[244],"are":[249,304],"not":[250],"only":[252],"blood.":[257],"Moreover,":[258],"could":[260],"detect":[261],"mitotic":[262],"imaging":[271],"nuclear":[276],"stain.":[277],"This":[278],"showed":[283],"surface":[286,395,435],"IgM,":[290,554],"CD86,":[291],"CCR7,":[292,555],"CXCR3":[293,556],"CXCR5":[295,558],"all":[297],"assessed":[300],"(p<0.05),":[301],"indicating":[302],"they":[303],"highly":[305],"primed":[308],"migration":[310,562],"lymph":[312],"nodes":[313],"(LNs)":[314],"further":[316],"activation":[317],"proliferation.":[319],"Proliferation":[320],"tissues,":[329],"however":[330,469],"tissue":[337,564],"unknown.":[339,481],"To":[340],"examine":[341],"LNs,":[349],"fine-needle":[353],"aspirate":[354],"obtained":[355],"enlarged":[358],"cervical":[359],"node":[360],"compared":[365],"this":[366,512],"matched":[369],"sample.":[371],"Flow":[372],"cytometric":[373],"gates":[374],"set":[375],"sample":[379],"used":[381],"define":[383],"quantify":[385],"LN":[386,418,430],"Expression":[389],"Ki67":[393,438],"IgM":[396,436],"which":[405],"expanded":[407],"20%":[409],"whilst":[419],"(accounting":[424],"2%":[426],"population)":[431],"expressed":[432],"very":[433],"low":[434],"levels,":[439],"suggesting":[440],"may":[445,578,586],"most":[448],"proliferative":[449],"CLL.":[452],"target":[466],"ibrutinib,":[468],"impact":[471],"ibrutinib":[473,484,519],"Administration":[482],"48hr":[490,518],"vitro":[492,522],"resulted":[493],"selective":[495],"targeted":[496],"depletion":[497],"fraction,":[503],"induction":[507],"apoptotic":[509],"markers":[510],"compartment;":[513],"conversely,":[514],"persistent":[515],"after":[517],"administration":[520],"exclusively":[524],"phenotype.":[529],"In":[530],"conclusion,":[531],"identified":[534],"potentially":[536],"dangerous":[537],"CXCR4,":[552],"CD5,":[553],"open":[559],"reception":[566],"signals.":[569],"Furthermore,":[570],"periphery":[577],"mirror":[580],"tissue-resident":[581],"phenotypes":[584],"represent":[587],"critical":[588],"targets":[589],"intervention,":[592],"particularly":[593],"high-risk":[595],"refractory":[598],"inhibitor":[601],"therapies.":[602],"Disclosures":[603],"Patten:":[604],"ROCHE:":[605],"Research":[606,611],"Funding;":[607,612],"GILEAD":[608],"SCIENCES:":[609],"Honoraria,":[610],"NOVARTIS:":[613],"Honoraria;":[614,616,619],"JANSSEN:":[615],"ASTRA":[617],"ZENECA:":[618],"ABBVIE:":[620],"Honoraria.":[621]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-12-31T00:00:00"}